Increased platelet deposition on atherosclerotic coronary arteries
about
Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosisCross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet ActivationThe thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cellsRac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque.Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents.Structural insight into the role of thrombospondin-1 binding to calreticulin in calreticulin-induced focal adhesion disassembly.Lysophosphatidic acid in atherosclerotic diseasesEvaluation of the physiological significance of botrocetin/ von Willebrand factor in vitro signaling.Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium.Humanizing thrombi in mice.Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner.Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions.Tissue factor expression in the symptomatic carotid plaqueIntercellular calcium communication regulates platelet aggregation and thrombus growth.A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivoState of the art in platelet function testing.Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.Microfluidic devices for studies of shear-dependent platelet adhesion.Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.Acute and persistent platelet and coagulant activities in atherothrombosis.Decreased platelet aggregation by shear stress-stimulated endothelial cells in vitro: description of a method and first results in diabetes.Pharmacodynamic models to evaluate antithrombotics in clinical pharmacology.Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl(3)-induced occlusive thrombus formation in the inferior vena cava of mice.Neutrophil granulocyte-dependent proteolysis enhances platelet adhesion to the arterial wall under high-shear flow.Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: impacts on thrombosis and thrombolysis.Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study.Pathological shear stress directly regulates platelet alphaIIbbeta3 signaling.
P2860
Q24297558-DE05F8F8-11F9-4B19-8189-29E8318C0D33Q28066352-E4A07906-E9FC-467A-9318-7ABE4C56AA8EQ28582206-7FE9645A-8134-4EE2-8317-E56E3BFE9AECQ30497856-521C493D-7E46-42BB-A7D0-7E41F1EE42FFQ33789829-EA373DEE-5953-4E15-A2B0-D51912E29C69Q34146710-6CB47C3D-AF18-4F2D-A740-206939BA94BBQ34273486-430C6022-DFC2-4B61-AF82-9BDCC82490E1Q34315106-E3F89017-B94D-4456-8CFF-160E76732427Q35039107-42FFFAEE-615D-43A8-B93F-E3451C0B434BQ35109254-BE66B4DA-0561-4CD9-82B2-0AE1BE4587D2Q35200296-16194B8B-39D2-41A3-898D-BCB8A58B76F8Q35656802-6752F044-1CCD-4170-B5D2-EB4F62BB35C1Q35868539-CD518260-A186-44B3-862C-551B80350193Q36323179-5729E2C6-311F-4121-9E89-0C0785E0097AQ36370457-87F9B843-FFF4-4177-8FBF-8AFDCCE9936CQ36802971-675940AC-3058-4A9C-A2CC-F10C427B26FBQ37142814-C6A1E6C3-12C1-47B0-B88C-5EB7FDE27902Q37196287-42C25B03-95AC-429B-9152-DF0B9F76089EQ37200463-C33D8C98-E0FF-412A-AB33-4B395A90B92BQ37511097-C0FE5FB4-BB6C-4D86-9D44-3C29D04331E4Q38543304-4819CB26-AF9E-4768-8B4F-AE47D097C0DBQ39107339-4BE96A63-2380-463A-BD54-F69655CDFF42Q41361483-04D66D4B-772E-4C7F-BA9D-8D78F7C239F7Q41578105-190B0899-1B23-4E5D-90B3-BBC29AA0F8B1Q42130284-32E11436-E465-4C00-A317-DDABF807540AQ42728181-02CFB871-31E9-4BCF-9C5D-A36CB2B696EFQ45242665-8BE43FA9-0862-4B4A-96DE-DC97D4B8B3E3Q45285281-2B7602D2-FD00-4FFB-BF23-960EDF5CF1F7Q51806105-6C5734E1-0A7E-400D-92F3-29350C5EFD8A
P2860
Increased platelet deposition on atherosclerotic coronary arteries
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Increased platelet deposition on atherosclerotic coronary arteries
@ast
Increased platelet deposition on atherosclerotic coronary arteries
@en
Increased platelet deposition on atherosclerotic coronary arteries
@nl
type
label
Increased platelet deposition on atherosclerotic coronary arteries
@ast
Increased platelet deposition on atherosclerotic coronary arteries
@en
Increased platelet deposition on atherosclerotic coronary arteries
@nl
prefLabel
Increased platelet deposition on atherosclerotic coronary arteries
@ast
Increased platelet deposition on atherosclerotic coronary arteries
@en
Increased platelet deposition on atherosclerotic coronary arteries
@nl
P2093
P2860
P356
P1476
Increased platelet deposition on atherosclerotic coronary arteries
@en
P2093
Connolly TM
Heijnen HF
Slootweg PJ
de Graaf S
de Groot PG
van Zanten GH
P2860
P304
P356
10.1172/JCI117014
P407
P577
1994-02-01T00:00:00Z